Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03830840 · ClinicalTrials.gov registry record
Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos
A clinical trial, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- 405
- Enrollment target
NCT03830840: Completed study, sponsored by Sansum Diabetes Research Institute.
NCT03830840 is a clinical trial that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 405 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03830840 has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- 405 participants
- Enrollment target
Study Summary
The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determinants of human health: genetics, biology, behavior, psychology, and society/environment.
Primary Outcome
The Mil Familias Cohort Establishment will expand upon the Mil Familias Operational Pilot cohort and infrastructure to collect and store the up to 100 proposed variables across the 5 determinants of human health to support long-term Mil Familias implementation. The variables pertaining to each participant will be collected and stored at the initial visit and then annually for up to 3 years. Socio-demographic characteristics of the cohort will be described at enrollment by type 2 diabetes status,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2022-03-29 |
What the finished NCT03830840 record still lists
NCT03830840 is an observational study that tracks outcomes without assigning an intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03830840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03830840 about?
NCT03830840 is a clinical study titled "Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos". The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determinants of human health: genetics, biology, behavior, psychology, and society/environment.
What is the current status of trial NCT03830840?
This trial is currently completed. The enrollment target is 405 participants. The study started on 2019-02-01. Estimated completion is 2022-03-29.
Who is sponsoring clinical trial NCT03830840?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- NCT07066657 · 405 participants · Phase 1
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI